Get the Stockscreener App
5.19
2.63%
-0.14
Pre-market:
5.34
0.15
+2.89%
Capsovision Inc stock is traded at $5.19, with a volume of 233.87K.
It is down -2.63% in the last 24 hours and up +3.80% over the past month.
CapsoVision Inc is a commercial-stage medical technology enterprise, innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. Internal GI imaging facilitates earlier detection of colorectal cancer and other diseases, enabling more timely and effective treatment regimens for patients. The Company's core technology platform is an orally ingestable capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. The Company's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D directed at the large intestines.
See More
Previous Close:
$5.33
Open:
$5.31
24h Volume:
233.87K
Relative Volume:
0.68
Market Cap:
$243.12M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.76%
1M Performance:
+3.80%
6M Performance:
+37.30%
1Y Performance:
+0.00%
1-Day Range:
$5.19
$5.455
1-Week Range:
$5.05
$5.66
52-Week Range:
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
Name
Capsovision Inc
Sector
Industry
Phone
(408) 370-4790
Address
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
5.19 | 249.67M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Initiated | Roth Capital | Buy |
| Jul-28-25 | Initiated | The Benchmark Company | Speculative Buy |
Capsovision Inc Stock (CV) Latest News
CapsoVision (CV) & Its Competitors Critical Contrast - Defense World
CapsoVision, Inc. (NASDAQ:CV) Short Interest Update - MarketBeat
Critical Survey: CapsoVision (CV) versus Its Rivals - Defense World
Financial Review: CapsoVision (CV) & Its Peers - Defense World
Head-To-Head Contrast: CapsoVision (CV) versus Its Competitors - Defense World
Critical Contrast: CapsoVision (CV) versus Its Rivals - Defense World
Head-To-Head Comparison: CapsoVision (CV) versus The Competition - Defense World
CapsoVision (NASDAQ:CV) and Profusa (NASDAQ:PFSA) Head-To-Head Review - Defense World
CapsoVision (CV) vs. Its Competitors Financial Analysis - Defense World
Reviewing CapsoVision (CV) & Its Competitors - Defense World
Is CapsoVision (NASDAQ:CV) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Head to Head Contrast: CapsoVision (CV) & Its Competitors - Defense World
Contrasting CapsoVision (CV) and The Competition - Defense World
Short Interest in CapsoVision, Inc. (NASDAQ:CV) Increases By 281.0% - MarketBeat
CapsoVision prices $27.5M IPO - MSN
Short Interest in CapsoVision, Inc. (NASDAQ:CV) Declines By 57.4% - MarketBeat
Reviewing Perspective Therapeutics (NASDAQ:CATX) & CapsoVision (NASDAQ:CV) - Defense World
CapsoVision seeks FDA clearance for AI endoscopy module - MSN
CapsoVision (CV) Price Target Increased by 75.00% to 10.71 - Nasdaq
CapsoVision (NASDAQ:CV) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
CapsoVision Submits 510(k) Application for CapsoCam AI-Assisted Module - Medical Product Outsourcing
CapsoVision price target raised to $14 from $5 at Benchmark - MSN
CapsoVision submits FDA 510(k) for AI-assisted module in CapsoCam Plus - MSN
US Smart Pills Market to Reach US$ 619.10 Million by 2033 | CAGR - openPR.com
CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus - Barchart.com
CapsoVision (NASDAQ:CV) Shares Gap DownHere's Why - MarketBeat
CapsoVision, Inc.'s (NASDAQ:CV) Path To Profitability - 富途牛牛
CapsoVision Shares Rise After Company Files 510(k) With US FDA to Add AI-Assisted Module to CapsoCam Plus - MarketScreener
CapsoVision (NASDAQ:CV) Shares Gap UpHere's What Happened - MarketBeat
CapsoVision, ACM Research And Other Big Stocks Moving Higher On Tuesday - Benzinga
CapsoVision Stock Pre-Market (-11%) : FDA 510(k) Submission for AI Module - Trefis
Verastem, TEN Holdings And 3 Stocks To Watch Heading Into Tuesday - Benzinga
CapsoVision submits FDA application for AI-assisted capsule endoscopy By Investing.com - Investing.com Nigeria
CapsoVision submits FDA application for AI-assisted capsule endoscopy - Investing.com
CapsoVision Seeks FDA Clearance for AI Endoscopy Module - TipRanks
CapsoVision Files 510(k) With US FDA to Add AI-Assisted Module to CapsoCam Plus - MarketScreener
CapsoVision Announces 510(k) Submission for the Addition of AI-Assisted Reading Module in CapsoCam Plus® - The Manila Times
CapsoVision, Inc Submits 510(k) Application for AI Module - TradingView — Track All Markets
Certain Common Stock of CapsoVision, Inc. are subject to a Lock-Up Agreement Ending on 29-DEC-2025. - MarketScreener
Certain Stock Options of CapsoVision, Inc. are subject to a Lock-Up Agreement Ending on 29-DEC-2025. - MarketScreener
Certain Warrants of CapsoVision, Inc. are subject to a Lock-Up Agreement Ending on 29-DEC-2025. - MarketScreener
CapsoVision (NASDAQ:CV) Shares Down 6.5% – Time to Sell? - Defense World
CapsoVision, Inc. (NASDAQ:CV) Short Interest Up 171.0% in December - MarketBeat
CapsoVision (NASDAQ:CV) Trading Down 6.5%Here's Why - MarketBeat
CapsoVision (NASDAQ:CV) Trading Up 12.9%Here's Why - MarketBeat
Honeywell, Intuitive Machines And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Sahm
Sidus Space, Starfighters Space And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Sahm
CapsoVision, Inc.’s Lock-Up Period Set To End on December 29th (NASDAQ:CV) - Defense World
CapsoVision Inc Trading Resumes - MSN
CapsoVision (NASDAQ:CV) Trading Down 3.1%Time to Sell? - MarketBeat
CapsoVision (NASDAQ:CV) Trading Up 7.3%Here's Why - MarketBeat
Capsovision Inc Stock (CV) Financials Data
There is no financial data for Capsovision Inc (CV). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):